Advertisement

Topics

NanoBio Corp. Company Profile

08:29 EDT 20th September 2018 | BioPortfolio

NanoBio® Corporation is a privately-held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal vaccines derived from its patented NanoStat® technology platform. The company’s lead product candidates are treatments for herpes labialis, onychomycosis, vaginitis, cystic fibrosis and a broad platform of intranasal vaccines. The company’s headquarters and laboratory facilities are located in Ann Arbor, Michigan.


News Articles [83 Associated News Articles listed on BioPortfolio]

NanoBio reorganizes under BlueWillow name; raises $10mm in Series A round

BlueWillow Biologics (formerly NanoBio; intranasal vaccines) closed a $10mm Series A round co-led by North Coast Technology Investors, Line Moon Ventures, and the University of Michigan's MINTS tech t...

Cell Sex a Factor in Nanoparticle Uptake and Efforts to Change Cell Fate

A nanoparticle may have little surface area, but it does represent a wide-open frontier in nanomedicine, which seeks to deploy nanoparticles in imaging, drug delivery, and cell reprogramming applicati...

Korea Investment CORP Boosts Stake in Mylan

Korea Investment CORP grew its position in Mylan by 462.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 736,474 shar...

CORRECTION from Source -- Emblem Corp.

TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- In Emblem’s Q2 release issued 22-Aug-2018 by Emblem Corp. over GlobeNewswire, we are advised by the company that corrections were made to the Adjusted E...

GTX Corp Announces New GPS Take-Along World Tracker for $89.00

LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an IoT platform and global provider of GPS tracking and monitoring wearable and wandering assistive technology, announced toda...

GTX Corp First Quarter 2018 Summary

Revenues increased 76%, Subscribers increased 79%, G&A decreased 17% LOS ANGELES, May 16, 2018 (GLOBE NEWSWIRE) -- GTX Corp. (OTCQB:GTXO), an IoT platform and leading provider of personal loc...

Emblem Corp. Issues President’s Letter to Shareholders

TORONTO, March 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) ("Emblem" or the "Corporation") provides a Letter to its Shareholders as follows: Spring is upon us, and Emblem is ...

Emblem Corp. Reports 2018 First Quarter Results

Strengthened team, new products, and key distribution partnerships driving demand NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 2...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Cell shape affects nanoparticle uptake and toxicity: An overlooked factor at the nanobio interfaces.

It is now being increasingly accepted that cells in their native tissue show different morphologies than those grown on a culture plate. Culturing cells on the conventional two-dimensional (2D) cultur...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [42 Associated Companies listed on BioPortfolio]

NanoBio Corp.

NanoBio® Corporation is a privately-held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal v...

Nanobiotix

NanoBio® Corp. is a privately held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal vaccine...

NanoBio Corporation

NanoBio Corporation is a privately held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal vacci...

NORLOFF COMPUTER CORP

Nil

ATLANTIS DRUG CORP

Nil

More Information about "NanoBio Corp." on BioPortfolio

We have published hundreds of NanoBio Corp. news stories on BioPortfolio along with dozens of NanoBio Corp. Clinical Trials and PubMed Articles about NanoBio Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NanoBio Corp. Companies in our database. You can also find out about relevant NanoBio Corp. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cystic Fibrosis
Affecting over 8,500 people in the UK, Cystic Fibrosis (CF) is one of the UK's most common life-threatening inherited diseases. Around half of the CF population can expect to live over 38 years, although improvements in treatments mean a baby born ...


Corporate Database Quicklinks



Searches Linking to this Company Record